Damora Therapeutics, Inc. (DMRA) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$209.84M | -878.8% |
| 2024 | -$21.44M | +44.1% |
| 2023 | -$38.35M | +37.8% |
| 2022 | -$61.62M | -19.1% |
| 2021 | -$51.75M | -48.6% |
| 2020 | -$34.84M | +4.6% |
| 2019 | -$36.51M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$209.84M | -878.8% |
| 2024 | -$21.44M | +44.1% |
| 2023 | -$38.35M | +37.8% |
| 2022 | -$61.62M | -19.1% |
| 2021 | -$51.75M | -48.6% |
| 2020 | -$34.84M | +4.6% |
| 2019 | -$36.51M | — |